Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shangjin Zhenggu Ding (伤筋正骨酊) is a traditional Chinese medicine (TCM) topical tincture developed and manufactured by Guizhou Shengshi Longfang Pharmaceutical. It is an external formulation indicated for the treatment of musculoskeletal injuries, including sprains, bruises, and conditions requiring bone-setting or trauma care. The tincture is applied topically to the affected area to promote healing, reduce swelling, and alleviate pain and inflammation. As a multi-component herbal preparation, it does not have a single defined molecular target but works through the combined effects of its constituent herbs. It is an approved pharmaceutical product in China with a National Medical Products Administration (NMPA) registration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shangjin zhenggu ding.